Ultragenyx Shares Enter 'Deeply Oversold' Territory After 44% Plunge

Shares of Ultragenyx (RARE) plunged over 44% in a single session, pushing the stock into a technically "deeply oversold" condition. While key indicators suggest the selling pressure is statistically stretched, the broader trend remains decidedly bearish, creating a complex setup for investors monitoring for a potential short-term rebound.

The Catalyst and the Collapse

Ultragenyx stock closed at $14.85 on September 3, a decline of 44.03% for the session, bringing it near its 52-week low of $13.81, according to market data from Investing.com. The sharp downturn coincided with significant price target reductions from Wall Street analysts following recent developments.

Goldman Sachs maintained a Neutral rating on the stock but cut its price target to $19 from a previous $28. Similarly, Barclays, while keeping an Overweight rating, lowered its target significantly to $32 from $43. These revisions suggest that while analysts see long-term value, near-term expectations have been sharply curtailed.

A Conflicting Technical Picture

The severe sell-off has created a stark conflict between short-term and trend-following indicators. While a premarket bounce to $15.40 was observed, the overall technical setup warrants caution, according to an analysis by Investing.com.

Ad

Key indicators highlight this divide:

• Relative Strength Index (RSI): At 19.1, the RSI is well below the 30 level that typically signals an oversold condition, suggesting the potential for a near-term bounce from exhausted sellers.
• Trend and Momentum: The daily Moving Average Convergence Divergence (MACD) and Average Directional Index (ADX) both maintain sell signals, indicating the downtrend has significant force and momentum.
• Overall Signal: Technical readings across daily, weekly, and monthly charts are rated as "Strong Sell," underscoring the dominant bearish trend.

Outlook: Bounce Potential vs. Confirmed Bottom

The current market action is being interpreted as a potential setup for an "oversold bounce" rather than a confirmed market bottom. The high volatility, reflected by an Average True Range (ATR) of 2.07, points to continued risk.

While an InvestingPro fair-value estimate cited by the source points to a potential upside at $31.13, the stock's performance remains under severe pressure, down 42.01% over the past week and 52.53% over the past year. A more durable reversal would likely require the stock to stabilize and hold above its recent lows before reclaiming key technical levels.